The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Run-off Property-Liability; Protection Services; Allstate Health and Benefits; and Corporate and Other. The company offers private passenger auto, homeowners, personal lines, and commercial insurance products through agents, contact centers, and online; and property and casualty insurance products. It also provides consumer product protection plans, device and mobile data collection services, and analytic solutions using automotive telematics information, roadside assistance, and protection plans; and insurance products, such as identity protection and restoration through Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity, and Allstate Identity Protection brands. In addition, the company offers life, accident, critical illness, hospital indemnity, short-term disability, and other health insurance products; self-funded stop-loss and fully insured group health products to employers; medicare supplement, ancillary products, and short-term medical insurance to individuals through independent agents, owned agencies, benefits brokers, and Allstate exclusive agents. Further, it offers automotive protection; vehicle service contracts, guaranteed asset protection, road hazard tires and wheels, and paintless dent repair protection; and roadside assistance, mobility data collection services, and analytic solutions using automotive telematics information, identity theft protection, and remediation services. The Allstate Corporation was founded in 1931 and is headquartered in Northbrook, Illinois.

Allstate Corporation (The)

Allot Communications (($ALLT)) has held its Q1 earnings call. Read on for the main highlights of the call. Allot Communications’ latest earnings ca...

Allot Communications Earnings Call Highlights SECaaS Surge

In a report released today, Adrian Lemme from Citi maintained a Buy rating on Aristocrat Leisure , with a price target of A$65.00. According to Tip...

Citi Sticks to Their Buy Rating for Aristocrat Leisure  (ARLUF)

Allarity Therapeutics ( ($ALLR) ) just unveiled an announcement. Allarity Therapeutics said it will begin using a new corporate presentation with i...

Allarity Highlights Stenoparib Progress in New Investor Presentation

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Trigano SA (TGNOF), Versigent Limited (VGNT) and Ball (BAL...

Analysts Offer Insights on Consumer Cyclical Companies: Trigano SA (OtherTGNOF), Versigent Limited (VGNT) and Ball (BALL)

In a report released today, Meyer Shields from KBW maintained a Buy rating on Allstate, with a price target of $266.00. Shields covers the Financia...

KBW Keeps Their Buy Rating on Allstate (ALL)

Value stocks are shares of companies that appear undervalued relative to their fundamentals. This means their stock price looks low compared with w...

3 Best Value Stocks to Buy in May 2026, According to Analysts 

Analysts have been eager to weigh in on the Financial sector with new ratings on Moelis (MC), First Interstate Bancsystem (FIBK) and Allstate (ALL)...

Analysts Have Conflicting Sentiments on These Financial Companies: Moelis (MC), First Interstate Bancsystem (FIBK) and Allstate (ALL)

Analysts fell to the sidelines weighing in on MARA Holdings (MARA) and Allstate (ALL) with neutral ratings, indicating that the experts are neither...

Analysts Are Neutral on These Financial Stocks: MARA Holdings (MARA), Allstate (ALL)

Analysts fell to the sidelines weighing in on Allstate (ALL) and Moelis (MC) with neutral ratings, indicating that the experts are neither bullish ...

Analysts Offer Insights on Financial Companies: Allstate (ALL) and Moelis (MC)

An announcement from Ball ( ($BALL) ) is now available. At its April 29, 2026 annual meeting of shareholders, Ball’s investors approved the company...

Ball Shareholders Approve Directors, Pay and Incentive Plan

Alleima AB ( ($SE:ALLEI) ) just unveiled an update. Alleima AB’s 2026 Annual General Meeting in Sandviken approved the 2025 accounts, discharged th...

Alleima AGM Approves Dividend, New Incentive Plan and Share Buyback Mandate

In a report released today, Alexander Virgo from Evercore ISI maintained a Buy rating on Allegion, with a price target of $175.00. According to Tip...

Evercore ISI Sticks to Their Buy Rating for Allegion (ALLE)

UBS analyst Haley Tam maintained a Hold rating on Allfunds Group plc today and set a price target of €9.25. Tam covers the Financial sector, focusi...

Allfunds Group plc (6UY) Gets a Hold from UBS

UBS analyst Andre Fromyhr maintained a Buy rating on Aristocrat Leisure today and set a price target of A$68.90. Fromyhr covers the Industrials sec...

UBS Sticks to Its Buy Rating for Aristocrat Leisure  (ARLUF)

SoFi Technologies ($SOFI) is entering what could be its most important earnings moment yet, as the company looks to prove its transition from a los...

SoFi (SOFI) Signals a Real Shift toward Profitability. Now Earnings Need to Confirm It

Morgan Stanley analyst Melinda Baxter maintained a Buy rating on Aristocrat Leisure on April 24 and set a price target of A$59.80. The company’s sh...

Aristocrat Leisure  (ARLUF) Receives a Buy from Morgan Stanley

Last week, stocks pushed to new highs as risk stayed firm and tech led the move. The Dow Jones (DJIA) fell 0.16% to 49,230, while the S&P 500 (SPX)...

The Week That Was, The Week Ahead: Macro and Markets, April 26

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Ally Financial (ALLY) and First Financial Bankshare...

Analysts’ Opinions Are Mixed on These Financial Stocks: Ally Financial (ALLY) and First Financial Bankshares (FFIN)

There’s a lot to be optimistic about in the Financial sector as 3 analysts just weighed in on Ally Financial (ALLY), Private Bancorp of America (PB...

Wall Street Analysts Are Bullish on Top Financial Picks

J.P. Morgan analyst Donald Carducci maintained a Buy rating on Aristocrat Leisure yesterday. The company’s shares closed yesterday at A$49.08. Acco...

Aristocrat Leisure  (ARLUF) Gets a Buy from J.P. Morgan

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Intercorp Financial Services (IFS), Equity Bancshar...

Analysts Conflicted on These Financial Names: Intercorp Financial Services (IFS), Equity Bancshares (EQBK) and Allstate (ALL)

Amid Iran war and AI-driven market jitters, investors could consider these three tech stocks, all rated “Strong Buy” by TipRanks’ Top Analysts. The...

3 Best Tech Stocks to Buy this Week 04/15/26, According to Top Analysts

Aristocrat Leisure ( ($AU:ALL) ) has shared an announcement. Aristocrat Leisure has disclosed the lapse of 432,449 performance share rights, which ...

Aristocrat Leisure Cancels Over 432,000 Lapsed Performance Share Rights

Aristocrat Leisure ( ($AU:ALL) ) has provided an announcement. Aristocrat Leisure Limited has notified the market of the issue of 80,693 ordinary f...

Aristocrat Leisure Issues 80,693 New Shares on Option Conversion

Aristocrat Leisure ( ($AU:ALL) ) just unveiled an update. Aristocrat Leisure Limited has notified the market of the issue of 263,295 unquoted perfo...

Aristocrat Issues New Performance Rights Under Employee Incentive Scheme

Aristocrat Leisure ( ($AU:ALL) ) has issued an announcement. Aristocrat Leisure Limited has notified the market of the issue of 14,977 unquoted per...

Aristocrat Issues New Performance Share Rights Under Employee Incentive Plan

Aristocrat Leisure ( ($AU:ALL) ) has shared an update. Aristocrat Leisure Limited has cancelled 3,586,342 ordinary fully paid shares as part of an ...

Aristocrat Leisure Cancels 3.6 Million Shares in Ongoing Buy-Back

Allogene Therapeutics ( ($ALLO) ) has shared an update. On April 13, 2026, Allogene Therapeutics announced it had commenced an underwritten public ...

Allogene Therapeutics Launches New Underwritten Common Stock Offering

Allegion received a Buy rating and a $175.00 price target from Evercore ISI analyst Alexander Virgo today. According to TipRanks, Virgo is ranked #...

Evercore ISI Initiates a Buy Rating on Allegion (ALLE)

The latest update is out from Allogene Therapeutics ( ($ALLO) ). On April 13, 2026, Allogene Therapeutics reported an interim futility analysis fro...

Allogene Highlights Positive Interim ALPHA3 CAR T Data

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Belite Bio, Inc. ADR (BLTE), Allogene Therapeutics (...

Current Quarter	$4.62	Next Quarter	$5.3
Current Year	$28.82	Next Year	$26.35
QoQ Growth	+14.7%	YoY Growth	-8.6%
3Y EPS CAGR	N/A	Target Price	$243.77
Consensus	Buy	Upside	+13.1%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ALL	$215.47	+0.78%	1.64M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ALL	$215.47	+0.8%	1.64M
3
4
5
6

ALL

ALL

EPS Estimates Overview

Quarterly EPS Estimates

Revenue Analysis

Get Allstate Corporation (The) Data in Excel

Get Allstate Corporation (The) Data in Excel